Seroatlas · Human Serome Atlas

CTSF

Cathepsin F

Also known as: CATF_HUMAN, CATSF, CLN13

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9UBX1
Gene
CTSF
Ensembl
ENSG00000174080
Chromosome
11
Canonical length
484 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Endoplasmic reticulum,Vesicles,Plasma membrane
Secretome location
Intracellular and membrane

OverviewNCBI Gene

Cathepsins are papain family cysteine proteinases that represent a major component of the lysosomal proteolytic system. Cathepsins generally contain a signal sequence, followed by a propeptide and then a catalytically active mature region. The very long (251 amino acid residues) proregion of the cathepsin F precursor contains a C-terminal domain similar to the pro-segment of cathepsin L-like enzymes, a 50-residue flexible linker peptide, and an N-terminal domain predicted to adopt a cystatin-like fold. The cathepsin F proregion is unique within the papain family cysteine proteases in that it contains this additional N-terminal segment predicted to share structural similarities with cysteine protease inhibitors of the cystatin superfamily. This cystatin-like domain contains some of the elements known to be important for inhibitory activity. CTSF encodes a predicted protein of 484 amino acids which contains a 19 residue signal peptide. Cathepsin F contains five potential N-glycosylation sites, and it may be targeted to the endosomal/lysosomal compartment via the mannose 6-phosphate receptor pathway. The cathepsin F gene is ubiquitously expressed, and it maps to chromosome 11q13, close to the gene encoding cathepsin W. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

484 residues, UniProt reviewed canonical sequence.

>Q9UBX1|CTSF
     1  MAPWLQLLSL LGLLPGAVAA PAQPRAASFQ AWGPPSPELL APTRFALEMF NRGRAAGTRA
    61  VLGLVRGRVR RAGQGSLYSL EATLEEPPCN DPMVCRLPVS KKTLLCSFQV LDELGRHVLL
   121  RKDCGPVDTK VPGAGEPKSA FTQGSAMISS LSQNHPDNRN ETFSSVISLL NEDPLSQDLP
   181  VKMASIFKNF VITYNRTYES KEEARWRLSV FVNNMVRAQK IQALDRGTAQ YGVTKFSDLT
   241  EEEFRTIYLN TLLRKEPGNK MKQAKSVGDL APPEWDWRSK GAVTKVKDQG MCGSCWAFSV
   301  TGNVEGQWFL NQGTLLSLSE QELLDCDKMD KACMGGLPSN AYSAIKNLGG LETEDDYSYQ
   361  GHMQSCNFSA EKAKVYINDS VELSQNEQKL AAWLAKRGPI SVAINAFGMQ FYRHGISRPL
   421  RPLCSPWLID HAVLLVGYGN RSDVPFWAIK NSWGTDWGEK GYYYLHRGSG ACGVNTMASS
   481  AVVD

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CTSF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.31
Highest tissue expression
124 nTPM

Expression across tissuesHPA

Tissue

  • choroid plexus: 124 nTPM
  • testis: 51 nTPM
  • blood vessel: 49 nTPM
  • basal ganglia: 47 nTPM
  • cerebellum: 46 nTPM
  • liver: 44 nTPM

Single-cell type

  • late spermatids: 537 nCPM
  • late primary spermatocytes: 296 nCPM
  • melanocytes: 203 nCPM
  • müller glia: 176 nCPM
  • early spermatids: 148 nCPM
  • ovarian stromal cells: 146 nCPM

Immune cell

  • naive CD4 T-cell: 6.4 nTPM
  • NK-cell: 4.7 nTPM
  • memory CD8 T-cell: 4.6 nTPM
  • MAIT T-cell: 4.2 nTPM
  • naive CD8 T-cell: 4.1 nTPM
  • gdT-cell: 3.9 nTPM

Brain region

  • choroid plexus: 129 nTPM
  • white matter: 118 nTPM
  • spinal cord: 103 nTPM
  • basal ganglia: 98 nTPM
  • hypothalamus: 96 nTPM
  • medulla oblongata: 96 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about CTSF.

Disease | AllUniProt

Conditions CTSF is implicated in, by any mechanism.

Disease | GeneticClinVar

37 pathogenic / likely-pathogenic of 321 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.2
gnomAD pLI
0
gnomAD missense Z
0.74
DepMap mean gene effect
-0.12
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CTSF as an antibody target. Whether an autoantibody or antibody against CTSF could matter depends on whether native CTSF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CTSF is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label CTSF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CTSF. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...